GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Asset Impairment Charge

Clal Biotechnology Industries (XTAE:CBI) Asset Impairment Charge : ₪0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Asset Impairment Charge?

Clal Biotechnology Industries's Asset Impairment Charge for the six months ended in Dec. 2024 was ₪0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was ₪0.00 Mil.


Clal Biotechnology Industries Asset Impairment Charge Historical Data

The historical data trend for Clal Biotechnology Industries's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Asset Impairment Charge Chart

Clal Biotechnology Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Clal Biotechnology Industries Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Clal Biotechnology Industries Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪0.00 Mil.


Clal Biotechnology Industries Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Clal Biotechnology Industries Business Description

Traded in Other Exchanges
N/A
Address
Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.

Clal Biotechnology Industries Headlines